fda indications for glp 1 Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the Adverse Event Reporting System database | BMC Medicine GLP-1 Medications for Weight Loss:

While obesity itself significantly increases venous thromboembolism risk, current evidence shows these injections do not add to that risk and may actually improve cardiovascular health through weight reduction

The association of glucose metabolism measures and diabetes status with Alzheimers disease biomarkers of amyloid and tau: a systematic review and meta-analysis

Future outlook Research into GLP-1 patches is progressing quickly, with several pharmaceutical companies reporting positive results from preclinical and early human studies

While these medications can offer powerful health benefits, theyre not without side effects

But again, kudos to my team